| Variable . | VHP-SD . | Control . | P . |
|---|---|---|---|
| Patients | 50 | 50 | |
| Age, years | 67 ± 10 | 66 ± 10 | 0.774 |
| LA volume, mL/m2a | 33 ± 10 | 37 ± 7 | 0.142 |
| Duration of AF, months | 28 ± 37 | 19 ± 27 | 0.263 |
| Female gender | 16 (32) | 19 (38) | 0.529 |
| Paroxysmal AF | 26 (52) | 24 (48) | 0.689 |
| Congestive heart failure | 7 (14) | 10 (20) | 0.424 |
| Arterial hypertension | 28 (56) | 29 (58) | 0.840 |
| Diabetes mellitus type 2 | 6 (12) | 2 (4) | 0.140 |
| Coronary artery disease | 12 (24) | 10 (20) | 0.629 |
| Previous TIA/Stroke | 3 (6) | 5 (10) | 0.461 |
| CHA2DS2-VASc score | |||
| ȃ0 | 8 (16) | 9 (18) | 0.790 |
| ȃ1 | 10 (20) | 5 (10) | 0.161 |
| ȃ2 | 9 (18) | 15 (30) | 0.249 |
| ȃ3 | 12 (24) | 10 (20) | 0.629 |
| ȃ≥4 | 11 (12) | 11 (32) | 0.999 |
| Variable . | VHP-SD . | Control . | P . |
|---|---|---|---|
| Patients | 50 | 50 | |
| Age, years | 67 ± 10 | 66 ± 10 | 0.774 |
| LA volume, mL/m2a | 33 ± 10 | 37 ± 7 | 0.142 |
| Duration of AF, months | 28 ± 37 | 19 ± 27 | 0.263 |
| Female gender | 16 (32) | 19 (38) | 0.529 |
| Paroxysmal AF | 26 (52) | 24 (48) | 0.689 |
| Congestive heart failure | 7 (14) | 10 (20) | 0.424 |
| Arterial hypertension | 28 (56) | 29 (58) | 0.840 |
| Diabetes mellitus type 2 | 6 (12) | 2 (4) | 0.140 |
| Coronary artery disease | 12 (24) | 10 (20) | 0.629 |
| Previous TIA/Stroke | 3 (6) | 5 (10) | 0.461 |
| CHA2DS2-VASc score | |||
| ȃ0 | 8 (16) | 9 (18) | 0.790 |
| ȃ1 | 10 (20) | 5 (10) | 0.161 |
| ȃ2 | 9 (18) | 15 (30) | 0.249 |
| ȃ3 | 12 (24) | 10 (20) | 0.629 |
| ȃ≥4 | 11 (12) | 11 (32) | 0.999 |
Values are counts, n (%), or mean (±SD).
AF, atrial fibrillation; LA, left atrium.
Per body surface area.
| Variable . | VHP-SD . | Control . | P . |
|---|---|---|---|
| Patients | 50 | 50 | |
| Age, years | 67 ± 10 | 66 ± 10 | 0.774 |
| LA volume, mL/m2a | 33 ± 10 | 37 ± 7 | 0.142 |
| Duration of AF, months | 28 ± 37 | 19 ± 27 | 0.263 |
| Female gender | 16 (32) | 19 (38) | 0.529 |
| Paroxysmal AF | 26 (52) | 24 (48) | 0.689 |
| Congestive heart failure | 7 (14) | 10 (20) | 0.424 |
| Arterial hypertension | 28 (56) | 29 (58) | 0.840 |
| Diabetes mellitus type 2 | 6 (12) | 2 (4) | 0.140 |
| Coronary artery disease | 12 (24) | 10 (20) | 0.629 |
| Previous TIA/Stroke | 3 (6) | 5 (10) | 0.461 |
| CHA2DS2-VASc score | |||
| ȃ0 | 8 (16) | 9 (18) | 0.790 |
| ȃ1 | 10 (20) | 5 (10) | 0.161 |
| ȃ2 | 9 (18) | 15 (30) | 0.249 |
| ȃ3 | 12 (24) | 10 (20) | 0.629 |
| ȃ≥4 | 11 (12) | 11 (32) | 0.999 |
| Variable . | VHP-SD . | Control . | P . |
|---|---|---|---|
| Patients | 50 | 50 | |
| Age, years | 67 ± 10 | 66 ± 10 | 0.774 |
| LA volume, mL/m2a | 33 ± 10 | 37 ± 7 | 0.142 |
| Duration of AF, months | 28 ± 37 | 19 ± 27 | 0.263 |
| Female gender | 16 (32) | 19 (38) | 0.529 |
| Paroxysmal AF | 26 (52) | 24 (48) | 0.689 |
| Congestive heart failure | 7 (14) | 10 (20) | 0.424 |
| Arterial hypertension | 28 (56) | 29 (58) | 0.840 |
| Diabetes mellitus type 2 | 6 (12) | 2 (4) | 0.140 |
| Coronary artery disease | 12 (24) | 10 (20) | 0.629 |
| Previous TIA/Stroke | 3 (6) | 5 (10) | 0.461 |
| CHA2DS2-VASc score | |||
| ȃ0 | 8 (16) | 9 (18) | 0.790 |
| ȃ1 | 10 (20) | 5 (10) | 0.161 |
| ȃ2 | 9 (18) | 15 (30) | 0.249 |
| ȃ3 | 12 (24) | 10 (20) | 0.629 |
| ȃ≥4 | 11 (12) | 11 (32) | 0.999 |
Values are counts, n (%), or mean (±SD).
AF, atrial fibrillation; LA, left atrium.
Per body surface area.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
